(NASDAQ: VTYX) Ventyx Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 70.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.01%.
Ventyx Biosciences's earnings in 2026 is -$106,607,000.On average, 10 Wall Street analysts forecast VTYX's earnings for 2026 to be -$124,099,807, with the lowest VTYX earnings forecast at -$156,646,482, and the highest VTYX earnings forecast at -$85,416,290. On average, 8 Wall Street analysts forecast VTYX's earnings for 2027 to be -$136,958,634, with the lowest VTYX earnings forecast at -$201,402,620, and the highest VTYX earnings forecast at -$84,667,024.
In 2028, VTYX is forecast to generate -$73,028,430 in earnings, with the lowest earnings forecast at -$160,143,055 and the highest earnings forecast at $133,369,294.